DRRX
NASDAQDURECT Corporation
Latest news
25 items- SECSEC Form 15-12G filed by DURECT Corporation15-12G - DURECT CORP (0001082038) (Filer)
- INSIDERAmendment: SEC Form 4 filed by President & CEO Brown James E4/A - DURECT CORP (0001082038) (Issuer)
- SECSEC Form EFFECT filed by DURECT CorporationEFFECT - DURECT CORP (0001082038) (Filer)
- INSIDERDirector Robertson Judith J. closing all direct ownership in the company (SEC Form 4)4 - DURECT CORP (0001082038) (Issuer)
- INSIDERPresident & CEO Brown James E returned 96,959 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - DURECT CORP (0001082038) (Issuer)
- INSIDERDirector Maderis Gail J closing all direct ownership in the company (SEC Form 4)4 - DURECT CORP (0001082038) (Issuer)
- INSIDERChief Medical Officer Sussman Norman returned 46,425 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - DURECT CORP (0001082038) (Issuer)
- INSIDERDirector Farfel Gail M closing all direct ownership in the company (SEC Form 4)4 - DURECT CORP (0001082038) (Issuer)
- INSIDERDirector Garcia Peter S closing all direct ownership in the company (SEC Form 4)4 - DURECT CORP (0001082038) (Issuer)
- INSIDERDirector Azab Mohammad closing all direct ownership in the company (SEC Form 4)4 - DURECT CORP (0001082038) (Issuer)
- INSIDERChief Financial Officer Papp Timothy M. returned 46,659 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - DURECT CORP (0001082038) (Issuer)
- INSIDERDirector Farfel Gail M exercised 5,500 shares at a strike of $1.22, increasing direct ownership by 55% to 15,500 units (SEC Form 4)4 - DURECT CORP (0001082038) (Issuer)
- INSIDERPresident & CEO Brown James E exercised 261,923 shares at a strike of $1.30, increasing direct ownership by 92% to 545,335 units (SEC Form 4)4 - DURECT CORP (0001082038) (Issuer)
- INSIDERDirector Robertson Judith J. exercised 5,500 shares at a strike of $1.22, increasing direct ownership by 15% to 41,113 units (SEC Form 4)4 - DURECT CORP (0001082038) (Issuer)
- INSIDERDirector Garcia Peter S exercised 5,500 shares at a strike of $1.22, increasing direct ownership by 79% to 12,500 units (SEC Form 4)4 - DURECT CORP (0001082038) (Issuer)
- INSIDERDirector Maderis Gail J exercised 5,500 shares at a strike of $1.22 (SEC Form 4)4 - DURECT CORP (0001082038) (Issuer)
- SECSEC Form S-8 POS filed by DURECT CorporationS-8 POS - DURECT CORP (0001082038) (Filer)
- SECSEC Form S-8 POS filed by DURECT CorporationS-8 POS - DURECT CORP (0001082038) (Filer)
- SECSEC Form S-8 POS filed by DURECT CorporationS-8 POS - DURECT CORP (0001082038) (Filer)
- SECSEC Form S-8 POS filed by DURECT CorporationS-8 POS - DURECT CORP (0001082038) (Filer)
- SECSEC Form S-8 POS filed by DURECT CorporationS-8 POS - DURECT CORP (0001082038) (Filer)
- SECSEC Form S-8 POS filed by DURECT CorporationS-8 POS - DURECT CORP (0001082038) (Filer)
- SECSEC Form S-8 POS filed by DURECT CorporationS-8 POS - DURECT CORP (0001082038) (Filer)
- SECSEC Form S-8 POS filed by DURECT CorporationS-8 POS - DURECT CORP (0001082038) (Filer)
- SECSEC Form S-8 POS filed by DURECT CorporationS-8 POS - DURECT CORP (0001082038) (Filer)
DRRX FAQ
6 questionsWhat does DURECT Corporation do?
DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops DUR-928, an endogenous, orally bioavailable small molecule that is in Phase IIb clinical trial to play a regulatory role in lipid homeostasis, inflammation, and cell survival, as well as completed Phase Ib clinical trial to treat patients with nonalcoholic steatohepatitis. In addition...Where does DRRX stock trade?
DURECT Corporation (DRRX) is listed on NASDAQ.What sector and industry is DRRX in?
DURECT Corporation operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.When did DURECT Corporation go public?
DURECT Corporation (DRRX) completed its IPO in 2000.What companies are similar to DRRX?
Notable peers in the same industry include LLY (Eli Lilly and Company), JNJ (Johnson & Johnson), AZN (AstraZeneca PLC), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.). Compare DRRX side-by-side with any of them on Quantisnow.How can I track DRRX on Quantisnow?
Quantisnow aggregates DURECT Corporation's SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow DRRX to receive live email and push alerts on every new disclosure.